{"doi":"10.1001/jamanetworkopen.2021.31913","title":"Valuing Alzheimer Disease Therapies—Considering Costs and Benefits Beyond the Patient","abstract":"disproportionate impact of AD on women (both as patients and caregivers), people of color, and low-resourced communities, future value assessments could also give credit to a treatment's ability to reduce health care disparities. 5 Furthermore, as Ito et al 1 note, new work suggests that society may be more willing to pay for therapies addressing severe diseases, such as AD, and thus warrant higher (ie, more lenient) cost-effectiveness benchmarks. suring that societal consequences of AD treatments receive attention will require a change in how the field conceptualizes the value of therapies. It will also require better data. In particular, data on caregiver costs and health effects should be core outcome measures and ideally collected alongside AD trials, as Ito et al 1 helpfully point out. Better estimates of how patient and caregiver utilities vary by disease stage and by care setting, among other data inputs, will also help to generate more robust cost-effectiveness estimates.","journal":"JAMA Network Open","year":2021,"id":199477,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9444,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":356434,"name":"Peter J. Neumann","orcid":"0000-0003-1226-4073","position":1,"is_corresponding":false},{"id":356431,"name":"Pei‐Jung Lin","orcid":"0000-0001-6707-4619","position":0,"is_corresponding":true}],"reference_count":4,"raw_metadata":null,"created_at":"2026-07-18T23:50:40.558460Z","pmid":"34677598","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}